Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells

[1]  S. Mordon,et al.  Endotoxin-induced myocardial dysfunction: Evidence for a role of sphingosine production* , 2004, Critical care medicine.

[2]  K. Gunter,et al.  Bcl-2 prevents abnormal mitochondrial proliferation during etoposide-induced apoptosis. , 2003, Experimental cell research.

[3]  R. Danesi,et al.  Cardiac toxicity of antineoplastic anthracyclines. , 2003, Current medicinal chemistry. Anti-cancer agents.

[4]  L. Corcos,et al.  Mitochondria as a Target for Inducing Death of Malignant Hematopoietic Cells , 2003, Leukemia & lymphoma.

[5]  C. Chi,et al.  Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence. , 2002, Journal of biomedical science.

[6]  B. van de Water,et al.  Differential Regulation of Doxorubicin-induced Mitochondrial Dysfunction and Apoptosis by Bcl-2 in Mammary Adenocarcinoma (MTLn3) Cells* , 2002, The Journal of Biological Chemistry.

[7]  S. Kaufmann,et al.  Apoptosis and the response to anticancer therapy , 2001, Current opinion in oncology.

[8]  E. Fleck,et al.  The Apoptotic Regulatory Protein ARC (Apoptosis Repressor with Caspase Recruitment Domain) Prevents Oxidant Stress-mediated Cell Death by Preserving Mitochondrial Function* , 2001, The Journal of Biological Chemistry.

[9]  K. Roemer,et al.  p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents , 2001, Oncogene.

[10]  P. Singal,et al.  Doxorubicin-induced cardiomyopathy. , 1998, The New England journal of medicine.

[11]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[12]  P. Paty,et al.  Mitochondrial Proliferation and Paradoxical Membrane Depolarization during Terminal Differentiation and Apoptosis in a Human Colon Carcinoma Cell Line , 1997, The Journal of cell biology.

[13]  K. Wallace,et al.  Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin. , 1996, Journal of molecular and cellular cardiology.

[14]  M. Castedo,et al.  Mitochondrial control of nuclear apoptosis , 1996, The Journal of experimental medicine.

[15]  J. Hickman,et al.  Changes of mitochondrial mass in the hemopoietic stem cell line FDCP-mix after treatment with etoposide: a correlative study by multiparameter flow cytometry and confocal and electron microscopy. , 1995, Experimental cell research.

[16]  S H Kaufmann,et al.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.

[17]  R. O. Poyton,et al.  Crosstalk between nuclear and mitochondrial genomes. , 1996, Annual review of biochemistry.

[18]  C. Riccardi,et al.  Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. , 1993, European journal of cancer.